Q: What novel surgical technique has had the most significant impact on your practice? Why?
Dr. Brian Dooreck: As more and more patients are interested in stopping chronic medical therapy with proton pump inhibitors, endoscopic therapy for the treatment of gastroesophageal reflux disease is evolving.
Patients are also looking for alternatives to traditional antireflux surgery. In my opinion, gastroenterologists need a better understanding of the therapeutic options, besides surgical intervention, to patients who cannot or do not wish to take chronic PPI medications for GERD.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
